Search
for
Sort by
Research 331–360 of 1000+
- From neural crest cells to melanocytes: cellular plasticity during development and beyond
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Regulation of melanocyte stem cell behavior by the niche microenvironment
- Novedades terapéuticas en tricología
- Combination of autologous FCS and MPG versus each technique alone in the treatment of stable vitiligo
- Advances In Mesenchymal Cell Therapy In Dermatology And Aesthetic Medicine
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Low Level Laser and Light Therapy
- Clinical Management in Psychodermatology
- Australasian Society for Dermatology Research Meeting, May 2006
- Dermatologic therapy: December 1987 to December 1988
- Classification of Surgical Therapies in Vitiligo
- Ethnopharmacological study about Glycyrrhiza glabra L. (Licorice) based on Ayurveda, An Indian System of Traditional Medicine- A Review
- Regeneration of rete ridges in Lanyu pig ( <i>Sus scrofa</i> ): Insights for human skin wound healing
- Study of Nonculture Epidermal Suspension in the Treatment of Stable Vitiligo
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- Potential Health Risks Associated with Cosmetics and Personal Care Products: An Overview
- Alopecia Areata
- Neuroimmunology of Stress: Skin Takes Center Stage
- Mucocutaneous reactions to chemotherapy
- The Skin in Pregnancy
- Skin diseases in consequence of endocrine alterations
- Morphological characteristics and notes of the skin in preclinical toxicity assessment
- Atlas of Geriatric Dermatology
- Cutaneous Manifestations of Chronic Kidney Disease: A Narrative Review
- The pathogenesis of alopecia areata
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Physiologic skin changes in pregnancy
- A review on traditional uses, phytochemistry and pharmacology of Eclipta prostrata (L.) L.
- Alopecia in patients treated with molecularly targeted anticancer therapies